General MedicationsINTRAVENOUSStandard
SODIUM FLUORIDE F-18
SODIUM FLUORIDE F-18
Standard Dose
10-200mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview SODIUM FLUORIDE F-18 is listed in Drugs@FDA under application 216126 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM FLUORIDE F-18 Form and strength INJECTABLE;INTRAVENOUS - 10-200mCi/ML Sponsor BAMF Submission history Latest submission status date: 2022-12-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview SODIUM FLUORIDE F-18 is listed in Drugs@FDA under application 216126 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM FLUORIDE F-18 Form and strength INJECTABLE;INTRAVENOUS - 10-200mCi/ML Sponsor BAMF Submission history Latest submission status date: 2022-12-06 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.